Correlation Between RenovoRx and Universe Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Universe Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Universe Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Universe Pharmaceuticals, you can compare the effects of market volatilities on RenovoRx and Universe Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Universe Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Universe Pharmaceuticals.

Diversification Opportunities for RenovoRx and Universe Pharmaceuticals

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between RenovoRx and Universe is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Universe Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universe Pharmaceuticals and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Universe Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universe Pharmaceuticals has no effect on the direction of RenovoRx i.e., RenovoRx and Universe Pharmaceuticals go up and down completely randomly.

Pair Corralation between RenovoRx and Universe Pharmaceuticals

Given the investment horizon of 90 days RenovoRx is expected to generate 0.45 times more return on investment than Universe Pharmaceuticals. However, RenovoRx is 2.23 times less risky than Universe Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Universe Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest  106.00  in RenovoRx on August 30, 2024 and sell it today you would earn a total of  20.00  from holding RenovoRx or generate 18.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  Universe Pharmaceuticals

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.
Universe Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

RenovoRx and Universe Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and Universe Pharmaceuticals

The main advantage of trading using opposite RenovoRx and Universe Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Universe Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universe Pharmaceuticals will offset losses from the drop in Universe Pharmaceuticals' long position.
The idea behind RenovoRx and Universe Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios